ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1965

Characterization of the Thyroid Hormone System in Rheumatoid Arthritis

Anna-Sophia Pörings1, Torsten Lowin2, Luise Rauch1, Tanja Späth1, Angelika Graeber2 and Rainer Straub3, 1Department of Internal Medicine I, Laboratory of Exp. Rheumatology and Neuroendocrino-Immunology, Regensburg, Germany, 2Department of Internal Medicine I, Laboratory of Exp. Rheumatology and Neuroendocrino-Immunology, University Hospital of Regensburg, Regensburg, Germany, 3Internal Medicine, University Hospital Regensburg, Regensburg, Germany

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: cytokines, synovial cells, synovial fluid and thyroid

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Cytokines, Mediators, Cell-cell Adhesion, Cell Trafficking and Angiogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Chronic inflammation is characterized by an energy appeal reaction supporting high energy demand of the activated immune system. Thyroid hormones are strongly associated with catabolic effects and are therefore important mediators of energy allocation. Until now, the role of thyroid hormones in the locally inflamed joint is unknown. This study investigates metabolism of thyroid hormones in the joint and demonstrates expression and regulation of thyroid hormone regulating elements in rheumatoid arthritis (RA) and osteoarthritis (OA).

Methods: Typical thyroid gland –related autoantibodies were detected in order to exclude patients with autoimmune thyroid disease. TSH and thyroid hormones in serum were detected by ELISA. Thyroid hormone receptors TRα, TRβ, TA-1, deiodinases DIO1/DIO2/DIO3 and thyroid transporter MOT-8 were stained immunohistochemically in paraffin embedded synovial tissue samples. Influences of cytokines on above-mentioned thyroid hormone related proteins were detected by cell-based ELISA. Thyroid receptor-related signaling was analyzed by proteome profiling.

Results: In RA and OA, serum levels of reverse triiodothyronine (rT3), the degradation product of T3, is higher in synovial fluid than in plasma which is opposite for T3 and thyroxine (T4). Serum rT3 relative to free T3 was higher in RA than OA. rT3 levels in superfusate of synovial tissue were higher in RA compared to OA. Staining of synovial tissue revealed expression of thyroid converting enzymes DIO1-3, transporter MOT-8 and nuclear receptors TRa and TRb. The addition of TNF or IL-1β to RA or OA synovial fibroblast cultures increased protein levels of DIO1, DIO3 and TRα. Furthermore, high expression of TA-1, a receptor for the degradation product of T3, iodothyronamine, was detected. In addition, synovial fibroblast MAP kinase signaling and IL-6 production was altered by thyroid hormones. 

Conclusion: Our data demonstrated that thyroid hormones are metabolized locally in the inflamed joint. This local inactivation is more pronounced in RA than OA (higher rT3 levels). Since cytokines alter the expression of DIO convertases and thyroid receptors, the thyroid hormone system might become dysregulated in the joint during chronic inflammation.


Disclosure:

A. S. Pörings,
None;

T. Lowin,
None;

L. Rauch,
None;

T. Späth,
None;

A. Graeber,
None;

R. Straub,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/characterization-of-the-thyroid-hormone-system-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology